register

News & Trends - Pharmaceuticals

Sanofi raises the bar for employee benefits, seeing the person as a whole individual

Health Industry Hub | March 27, 2024 |

Among all chronic conditions, individuals diagnosed with cancer face the highest prevalence of employment loss. In this Health Industry Hub interview, Michelle Zimany, People Business Partner Lead for Specialty Care in the Japan Pacific region at Sanofi, delved into the critical intersection of employment and cancer diagnosis, and a first-of-its-kind program raising the bar for employee benefits in the healthcare industry.

“50% of individuals diagnosed with cancer are afraid to tell their workplace. This is despite 92% saying that their workplace plays a critical role in how they’re feeling about their health, particularly mentally,” she explained.

The inception of Sanofi’s Cancer & Work global program stemmed from an inspiring employee initiative in 2017. Ms Zimany shared a story of a Sanofian who was the driving force behind the initiative, choosing to “fight to live her life. Not just to survive, but really to continue to do the things that gave her meaning and purpose.”

When asked about the tangible benefits of the Cancer & Work program for employees locally, she emphasised its role in offering a holistic approach, ranging from peer support, flexible work arrangements and salary protection for a year.

“We’ve had some people who are in remission say that if the Cancer & Work program had been available when they were diagnosed, it would have changed their whole outlook on how they approached work,” she shared.

The launch of the Cancer & Work program aligns seamlessly with Sanofi’s short- and long-term Diversity, Equity, and Inclusion (DE&I) strategy.

“Our vision is to reflect the diversity of our communities and ensure that we’re enabling people to unleash their full potential in order to transform healthcare,” she stated.

In closing, Ms Zimany offered invaluable advice to organisations contemplating similar programs. She stressed the importance of “really looking within your own organisation to help accelerate great ideas” and to “go slow in order to go fast”.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Parliament passes lung cancer legislation

Parliament passes lung cancer legislation

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Lung cancer is the leading cause of cancer death and is responsible for almost one in […]

More


News & Trends - Pharmaceuticals

Senator Ruston criticises Budget's lack of 'real seamanship' in tackling pressing healthcare challenges

Senator Ruston criticises Budget’s lack of ‘real seamanship’ in tackling pressing healthcare challenges

Health Industry Hub | May 17, 2024 |

Pharma News: Senator Anne Ruston, Shadow Health Minister, was warmly welcomed at the Post-Budget event held in Parliament House yesterday […]

More


News & Trends - MedTech & Diagnostics

Baxter announces branding for spin-off kidney care business

Baxter announces branding for spin-off kidney care business

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Baxter has unveiled the mission and logo for its forthcoming kidney care and acute therapies company, […]

More


ESG

Health and climate strategy: All talk, no budget

Health and climate strategy: All talk, no budget

Health Industry Hub | May 16, 2024 |

ESG: The Federal Budget has sparked disappointment among health professionals for its lack of attention to addressing the escalating impacts […]

More


This content is copyright protected. Please subscribe to gain access.